IGM Biosciences
Utility Patents
Last updated:
List of all IGM Biosciences patents 12 in total
Status | Patent |
---|---|
Grant | Utility: Modified human IgM constant regions for modulation of complement-dependent cytolysis effector function Filling date: 26 Sep 2025 Issue date: 2 Aug 2022 |
Grant | Utility: Multi-valent human immunodeficiency virus antigen binding molecules and uses thereof Filling date: 26 Sep 2025 Issue date: 7 Dec 2021 |
Grant | Utility: Modified J-chain Filling date: 26 Sep 2025 Issue date: 13 Apr 2021 |
Grant | Utility: Anti-PD-L1 antibodies Filling date: 26 Sep 2025 Issue date: 23 Mar 2021 |
Grant | Utility: IgM Fc and J-chain mutations that affect IgM serum half-life Filling date: 26 Sep 2025 Issue date: 26 Jan 2021 |
Grant | Utility: IgA multi-specific binding molecules Filling date: 26 Sep 2025 Issue date: 3 Nov 2020 |
Grant | Utility: Multimeric bispecific binding molecules specific for CD20 and CD3 Filling date: 26 Sep 2025 Issue date: 29 Sep 2020 |
Grant | Utility: Multimeric death domain-containing receptor-5 (DR5) antibodies and uses thereof Filling date: 26 Sep 2025 Issue date: 23 Jun 2020 |
Grant | Utility: Binding molecules with modified J-chain Filling date: 26 Sep 2025 Issue date: 14 Apr 2020 |
Grant | Utility: Multi-valent hepatitis B virus antigen binding molecules and uses thereof Filling date: 26 Sep 2025 Issue date: 31 Mar 2020 |
Grant | Utility: Multi-valent human immunodeficiency virus antigen binding molecules and uses thereof Filling date: 26 Sep 2025 Issue date: 25 Feb 2020 |
Grant | Utility: Modified J-chain Filling date: 26 Sep 2025 Issue date: 3 Sep 2019 |
Showing 1 to 12 of 12 patents.